Principal Financial Group Inc Cullinan Oncology, Inc. Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
SELL
$7.89 - $10.23 $1,428 - $1,851
-181 Reduced 1.66%
10,692 $108,000
Q3 2023

Nov 02, 2023
BUY
$9.05 - $11.72 $7,565 - $9,797
836 Added 8.33%
10,873 $98,000
Q2 2023

Aug 07, 2023
SELL
$8.8 - $13.4 $1,522 - $2,318
-173 Reduced 1.69%
10,037 $107,000
Q1 2023

May 09, 2023
BUY
$10.2 - $11.91 $104,142 - $121,601
10,210 New
10,210 $104,000

Others Institutions Holding CGEM

# of Institutions
146
Shares Held
67.6M
Call Options Held
612K
Put Options Held
118K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $613M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email